Name: Innovation versus Financialization in the US Pharmaceutical Industry - Tulum, Oner (The Academic-Industry Research Network), Lazonick, William (The Academic-Industry Research Network)
Price: 31.15 EUR
Author: Tulum, Oner (The Academic-Industry Research Network), Lazonick, William (The Academic-Industry Research Network)
ISBN: 9781009707985

Innovation versus Financialization in the US Pharmaceutical Industry

Tulum, Oner (The Academic-Industry Research Network), Lazonick, William (The Academic-Industry Research Network)

Description

The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.'

In the shopping cart Delivered in 5 business days. Wishlist Ask a question

Free shipping from
€ 19,95 within The Netherlands

Writer: Tulum, Oner (The Academic-Industry Research Network), Lazonick, William (The Academic-Industry Research Network)
Title: Innovation versus Financialization in the US Pharmaceutical Industry
Publisher: Cambridge University Press

Year: 2025
Language: English
Pages: 96

EAN: 9781009707985
Binding format: Paperback / softback

You will always receive the last edition from us!

Innovation versus Financialization in the US Pharmaceutical Industry

Tulum, Oner (The Academic-Industry Research Network), Lazonick, William (The Academic-Industry Research Network)

Description

Categories

Ask a question